Form D · Biotechnology
LORUS THERAPEUTICS INC
Toronto, A6 · CIK 0000882361
Offering snapshot reported Apr 24, 2014 · SEC filing
- Reported sold
- $28.3M Offering amount: $28.8M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 10, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 24, 2014 | Initial | $28,250,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $1.98M
- Finders' fees
- $0
- Form D file number
- 021-216147
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| RBC Dominion Securities Inc. | None | RBC Dominion Securities Inc. |
| Roth Capital Partners, LLC | 15407 | Roth Capital Partners, LLC · CRD 15407 |
| Cormark Securities Inc. | 101000 | Cormark Securities Inc. · CRD 101000 |
Source: Form D, filed Apr 24, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Denis Burger | Director |
| Gregory Chow | Executive |
| William G Rice | Director, Executive |
| Brad Thompson | Director |
| Brian Underdown | Director |
| Avanish Vellanki | Executive |
| Mark Vincent | Director |
| Warren Whitehead | Director |
| Jim A Wright | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2 Meridian Road .
Toronto, A6, M9W 4Z7
Toronto, A6, M9W 4Z7